Search Within

James Joseph Harding

Formats
  1. Meeting Abstract (124)
  2. Journal Article (115)
  3. Review (7)
  4. Book Section (3)
  5. Miscellaneous (3)
Groups
  1. Department of Medicine (252)
  2. Gastrointestinal Oncology Service (252)
  3. Solid Tumor Oncology Division (252)
  4. Center for Pancreatic Cancer Research (129)
  5. GSK Faculty (99)
  6. Epidemiology and Biostatistics (89)

More Groups

People
  1. Ghassan Abou-Alfa (130)
  2. Eileen O'Reilly (70)
  3. William Jarnagin (59)
  4. Michael D'Angelica (40)
  5. Andrea Cercek Hanjis (38)
  6. Michael Berger (37)

More People

Years
  1. 2025 (13)
  2. 2024 (32)
  3. 2023 (34)
  4. 2022 (21)
  5. 2021 (23)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Annals of Oncology (17)
  3. Clinical Cancer Research (15)
  4. Annals of Surgical Oncology (13)
  5. Cancer (9)
  6. JCO Precision Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (99)
  2. Oxford University Press (25)
  3. American Association for Cancer Research (23)
  4. Springer (20)
  5. Wiley Blackwell (14)
  6. Elsevier Science, Inc. (10)

More Publishers

Results (252)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ia/Ib study of an anti-TIM-3 antibody (LY3321367) monotherapy or in combination with an anti-PD-L1 antibody (LY3300054): Interim safety, efficacy, and pharmacokinetic findings in advanced cancers
    Meeting Abstract

    Harding, J. J.; Patnaik, A.; Moreno, V.; Stein, M.; Jankowska, A. M.; de Mendizabal, N. V.; Liu, Z. T.; Koneru, M.; Calvo, E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CB-839, a glutaminase inhibitor, in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer (mRCC): Results of a phase I study
    Meeting Abstract

    Meric-Bernstam, F.; Lee, R. J.; Carthon, B. C.; Iliopoulos, O.; Mier, J. W.; Patel, M. R.; Tannir, N. M.; Owonikoko, T. K.; Haas, N. B.; Voss, M. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase II study of ADI-PEG 20 and FOLFOX6 in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Qin, S.; Yang, T. S.; Yen, C. J.; Chao, Y.; Wang, T. E.; Do, R. K. G.; El Dika, I. H.; Uhlitskykh, K.; Millang, B. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A retrospective study of hepatic arterial infusion (HAI) FUDR/Dex and mitomycin C (MMC) for chemotherapy refractory unresectable intrahepatic cholangiocarcinomas (ICC)
    Meeting Abstract

    Dos Santos Fernandes, G.; Kemeny, N. E.; Hauser, H.; Harding, J. J.; Boerner, T.; Varghese, A. M.; Kingham, P.; D'Angelica, M. I.; DeMatteo, R. P.; Drebin, J. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Preliminary safety and pharmacokinetics of a new lysosomotropic oral agent, GNS561, in a first-in-human study in advanced primary liver cancer patients
    Meeting Abstract

    Abou-Alfa, G. K.; Harding, J. J.; Awada, A.; Kotecki, N.; Aftimos, P.; Decaens, T.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Serdjebi, C.; more...
    Hepatology (2019)

    Fulltext@MSK | Save
  • Preliminary results of PROCLAIM-CX-2009, a first-in-human, dose-finding study of the Probody drug conjugate CX-2009 in patients with advanced solid tumors
    Meeting Abstract

    Meric-Bernstam, F.; Boni, V.; Spira, A. I.; Sanborn, R. E.; Arkenau, H. T.; Sweis, R.; Burris, H.; Li, R.; Yalamanchili, S.; Will, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • In situ vaccination with defined factors overcomes T cell exhaustion in distant tumors
    Journal Article

    Khalil, D. N.; Suek, N.; Campesato, L. F.; Budhu, S.; Redmond, D.; Samstein, R. M.; Krishna, C.; Panageas, K. S.; Capanu, M.; Houghton, S.; more...
    Journal of Clinical Investigation (2019)

    Fulltext@MSK | Save
  • A phase Ib/II study of ramucirumab in combination with emibetuzumab in patients with advanced cancer
    Journal Article

    Harding, J. J.; Zhu, A. X.; Bauer, T. M.; Choueiri, T. K.; Drilon, A.; Voss, M. H.; Fuchs, C. S.; Abou-Alfa, G. K.; Wijayawardana, S. R.; Wang, X. A.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Aspirin is associated with improved liver function after embolization of hepatocellular carcinoma
    Journal Article

    Boas, F. E.; Brown, K. T.; Ziv, E.; Yarmohammadi, H.; Sofocleous, C. T.; Erinjeri, J. P.; Harding, J. J.; Solomon, S. B.
    American Journal of Roentgenology (2019)

    Fulltext@MSK | Save
  • Treating HER2-mutant advanced biliary tract cancer with neratinib: Benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket; trial
    Meeting Abstract

    Harding, J.; Cleary, J.; Shapiro, G.; Braña, I.; Moreno, V.; Quinn, D.; Borad, M.; Loi, S.; Spanggaard, I.; Stemmer, S.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save